Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Zheng, Hao  [Clear All Filters]
2024
Zheng H, Wu D, Chen X, He W, Hua J, Li Q, Ji YQ. Endothelial downregulation of nuclear m6A reader YTHDC1 promotes pulmonary vascular remodeling in sugen hypoxia model of pulmonary hypertension. Heliyon. 2024;10(3):e24963.
Zheng H, Liu J, Cheng Q, Zhang Q, Zhang Y, Jiang L, Huang Y, Li W, Zhao Y, Chen G, et al. Targeted activation of ferroptosis in colorectal cancer via LGR4 targeting overcomes acquired drug resistance. Nat Cancer. 2024.
2023
Wang S, Fang L, Zhou H, Wang M, Zheng H, Wang Y, Weir MD, Masri R, Oates TW, Cheng L, et al. Silica nanoparticles containing nano-silver and chlorhexidine respond to pH to suppress biofilm acids and modulate biofilms toward a non-cariogenic composition. Dent Mater. 2023.
2022
Cheng Q, Zheng H, Li M, Wang H, Guo X, Zheng Z, Chen C, Liu J, Zhan T, Li Z, et al. LGR4 cooperates with PrPc to endow the stemness of colorectal cancer stem cells contributing to tumorigenesis and liver metastasis. Cancer Lett. 2022:215725.
2021
Zhang Y, Zheng H, Ren J, Luo X, Zheng Z, Zheng J, Zheng X, Chen Y, Chen Z, Hu J, et al. Mesenchymal stem cells enhance the impact of KIR receptor-ligand mismatching on acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia but not in those with acute lymphocytic le. Hematol Oncol. 2021.
Du L, Cheng Q, Zheng H, Liu J, Liu L, Chen Q. Targeting stemness of cancer stem cells to fight colorectal cancers. Semin Cancer Biol. 2021.
2016
Yang T, Lin Q, Ren J, Chen P, Yuan X, Luo X, Liu T, Zheng J, Zheng Z, Zheng X, et al. A 5-day cytoreductive chemotherapy followed by haplo-identical hsct (FA5-BUCY) as a tumor-ablative regimen improved the survival of patients with advanced hematological malignancies. Oncotarget. 2016.